Hypera SA (Brazil) Insiders

HYPE3 Stock  BRL 20.05  0.45  2.20%   
Hypera SA employs about 9 K people. The company is managed by 21 executives with a total tenure of roughly 135 years, averaging almost 6.0 years of service per executive, having 428.57 employees per reported executive. Breaking down Hypera SA's management performance can provide insight into the firm performance.
Juliana Salem  Insider
Legal Officer
Breno Oliveira  Executive
Investor Relations Officer, Member of the Executive Board
  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hypera SA. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Hypera SA Management Team Effectiveness

The company has return on total asset (ROA) of 0.0686 % which means that it generated a profit of $0.0686 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1626 %, meaning that it generated $0.1626 on every $100 dollars invested by stockholders. Hypera SA's management efficiency ratios could be used to measure how well Hypera SA manages its routine affairs as well as how well it operates its assets and liabilities.

Hypera SA Workforce Comparison

Hypera SA is rated # 4 in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 122,453. Hypera SA holds roughly 9,000 in number of employees claiming about 7% of equities under Health Care industry.
The company has Profit Margin (PM) of 0.23 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.33 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.33.

Hypera SA Benchmark Summation

Operator
The output start index for this execution was zero with a total number of output elements of sixty-one. Hypera SA Price Series Summation is a cross summation of Hypera SA price series and its benchmark/peer.

Hypera SA Notable Stakeholders

A Hypera SA stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Hypera SA often face trade-offs trying to please all of them. Hypera SA's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Hypera SA's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Adalmario CoutoChief Financial Officer, Investor Relations Officer, Business Development OfficerProfile
Martim MattosChief Financial Officer, Chief Controllership Officer, Member of the Executive BoardProfile
Vivian AngiolucciChief Operating Officer, Member of the Executive BoardProfile
Carlos ScorsiCOO, Member of the Executive BoardProfile
Maria LacerdaIndependent Member of the Board of DirectorsProfile
David CouryIndependent Member of the Board of DirectorsProfile
Alvado LinkMember of the Board of DirectorsProfile
Bernardo HernandezMember of the Board of DirectorsProfile
Esteban FomperosaMember of the Board of DirectorsProfile
Juliana SalemLegal OfficerProfile
Breno OliveiraInvestor Relations Officer, Member of the Executive BoardProfile
Luciana QueirozMember of the Board of DirectorsProfile
David NetoIndependent Member of the Board of DirectorsProfile
Rafael BatistaExecutive OfficerProfile
Flair CarrilhoIndependent Member of the Board of DirectorsProfile
Hlio SegourasHead HealthProfile
Hugo LealMember of the Board of DirectorsProfile
Joao AguilarRisks OfficerProfile
Mauricio ChristovamHR OfficerProfile
Nelson MelloInstitutional Relations Officer, Member of the Executive BoardProfile
Luiz ClavisCommercial and Marketing Vice PresidentProfile

About Hypera SA Management Performance

The success or failure of an entity such as Hypera SA often depends on how effective the management is. Hypera SA management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Hypera management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Hypera management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
It offers branded prescription products under the Mantecorp Farmasa, Episol, Predsim, Alivium, Lisador, Rinosoro, Celestamine, Maxsulid, Diprospan, Mioflex-A, and Addera D3 brands dermo-cosmetics products under the Mantecorp Skincare brands and consumer health products under the Apracur, Benegrip, Coristina d, Engov, Epocler, Estomazil, and other brands. Hypera S.A. was founded in 2001 and is headquartered in So Paulo, Brazil. HYPERA ON operates under Drug ManufacturersSpecialty Generic classification in Brazil and is traded on Sao Paolo Stock Exchange. It employs 8918 people.
Please note, the imprecision that can be found in Hypera SA's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Hypera SA. Check Hypera SA's Beneish M Score to see the likelihood of Hypera SA's management manipulating its earnings.

Hypera SA Workforce Analysis

Traditionally, organizations such as Hypera SA use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Hypera SA within its industry.

Hypera SA Manpower Efficiency

Return on Hypera SA Manpower

Revenue Per Employee659.7K
Revenue Per Executive282.7M
Net Income Per Employee147.8K
Net Income Per Executive63.3M
Working Capital Per Employee560.3K
Working Capital Per Executive240.1M

Additional Tools for Hypera Stock Analysis

When running Hypera SA's price analysis, check to measure Hypera SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hypera SA is operating at the current time. Most of Hypera SA's value examination focuses on studying past and present price action to predict the probability of Hypera SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hypera SA's price. Additionally, you may evaluate how the addition of Hypera SA to your portfolios can decrease your overall portfolio volatility.